Elevated IRS‐1 pS616 Pathology in Human Hippocampal Area CA1 as a Biomarker of Preclinical and Alzheimer's Disease Dementia
Xuelin Gu, Tim Distel, Konrad Talbot · 2025
Read Elevated IRS‐1 pS616 Pathology in Human Hippocampal Area CA1 as a Biomarker of Preclinical and Alzheimer's Disease Dementia by Xuelin Gu, Tim Distel, Konrad Talbot (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714677.txt.
Description
Xuelin Gu, Tim Distel, and Konrad Talbot hunt a brain marker of insulin resistance in Alzheimer's disease in a 2025 study. The brain's poor response to insulin is common in the disease, but no clear tissue marker for it existed.
One candidate is a signaling protein tagged at a specific site. In healthy brains the tag sits mostly in cell nuclei of a key memory region. In Alzheimer's brains it spreads into the cell body. The team stained tissue from 217 donors across five groups, from healthy to full dementia, and let a trained network count the marked cells. They ask whether the shift flags disease before symptoms, as a preclinical marker beside the standard amyloid and tau measures.
Catalog record
| CREATOR | Xuelin Gu, Tim Distel, Konrad Talbot |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |